Skip to main content
. 2015 Jul 27;2015(7):CD011242. doi: 10.1002/14651858.CD011242.pub2

Kopp Kallner 2015.

Methods Randomised controlled trail
Carried out in 2011‐2012 in Sweden in an outpatient family planning clinic
Women who made an appointment by calling the clinic by telephone were informed about the study and invited to participate
Participants Women were eligible to participate if they: had a gestation of 63 days or less according to their last menstrual period; were 18 years or older; had no contraindication for medical abortion; were in good general health; were not taking any continuing medication for chronic disease
Interventions 2 nurse midwives experienced in medical abortion and contraceptive counselling received theoretical and practical training in vaginal ultrasound examination of early pregnancy
These nurse midwives were the sole providers in the nurse midwife arm
There were a total of 34 doctors with varying levels of training and experience in the standard care arm
Women randomised to the nurse‐midwife arm were counselled, examined, informed and treated by a single nurse midwife. Nurse‐midwives in this arm did not perform any other tasks during the study period
Women randomised to the standard care arm were examined and counselled by the doctor and then received additional information about the practical details and medication from a nurse midwife, according to clinical routine
All women received 200 mg of mifepristone in the clinic
Women then had the choice of receiving 800 µg of misoprostol vaginally at home or in the clinic 24 to 48 hours after mifepristone administration. If no bleeding occurred within 3 hours, women were instructed to take an additional dose of 400 µg of misoprostol orally
Women were followed up after 3 weeks and given a urinary hCG test. If the results were positive a serum hCG test was performed and they were referred for evaluation with vaginal ultrasound
Complications were followed up for 6 weeks
MLPs and doctors worked at the same site
Outcomes The primary outcome was efficacy, defined as the need for surgical intervention
Secondary outcomes:
Safety, defined as no complications up to 6 weeks after the procedure
Hospitalisation or blood transfusion
Acceptability, defined as women preferring their allocated provider
Outcomes were assessed by questionnaires at follow‐up visit
Notes
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Computer‐generated sequence
Allocation concealment (selection bias) Low risk Sealed, opaque envelopes
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk The participant was aware of the provider type. We do not consider this to be a bias because this is part of the intervention. If MLPs are to perform abortion procedures outside of study conditions, we would expect patients to be aware of the provider type. We therefore do not consider the lack of blinding to provider type to bias the results of the study
Blinding of outcome assessment (detection bias) 
 All outcomes High risk No blinding
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Low loss to follow‐up, similar in each group
Selective reporting (reporting bias) Low risk Protocol made available prior to study
Other bias Unclear risk No other bias detected